Synapse - Center for Hematologic Malignancies

Results (13553)

Mutation profiling of therapy-related myeloid neoplasms using next-generation sequencing demonstrates distinct profiles from de novo disease

Meeting Abstract

Shih, A. H.; Rapaport, F.; Chung, S. S.; Dolezal, E. K.; Hobson, S.; Amato, M. K.; Park, C. Y.; Sekeres, M. A.; van den Brink, M. R. M.; Nimer, S.; more...
Blood (2014)

Fulltext@MSK | Save

Second interim analysis of a phase 3 study of idelalisib (ZYDELIG®) plus rituximab (R) for relapsed chronic lymphocytic leukemia (CLL): Efficacy analysis in patient subpopulations with del(17p) and other adverse prognostic factors

Meeting Abstract

Sharman, J. P.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
Blood (2014)

Fulltext@MSK | Save

Mathematical optimization of JAK inhibitor dose and scheduling for MPN patients

Meeting Abstract

Shank, K. R.; Koppikar, P.; Bhagwat, N.; Keller, M. D.; Michor, F.; Levine, R. L.; Roditi, L. D.
Blood (2014)

Fulltext@MSK | Save

Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia

Meeting Abstract

Seddon, A. N.; Michael, A. G.; Adel, N. G.; Tallman, M. S.; Akin, O.; Chaim, J.; Drill, E.
Blood (2014)

Fulltext@MSK | Save

A Cutaneous Lymphoma International Consortium 'CLIC' study of prognostic parameters in advanced stages of mycosis fungoides and Sezary syndrome: Progress towards establishing a prognostic index to augment clinical staging

Meeting Abstract

Scarisbrick, J. J.; Quaglino, P.; Vermeer, M.; Whittaker, S.; Wood, G. S.; Duvic, M.; Prince, M.; Horwitz, S. M.; Hoppe, R. T.; Porcu, P.; more...
Blood (2014)

Fulltext@MSK | Save

Myeloablative double-unit cord blood transplantation (CBT) in pediatric patients with high-risk acute leukemia demonstrates encouraging disease-free survival with both TBI and chemotherapy-only-based conditioning

Meeting Abstract

Scaradavou, A.; Lubin, M. N.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
Blood (2014)

Fulltext@MSK | Save

Safe and effective treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) and low baseline platelet counts with belinostat

Meeting Abstract

Savage, K. J.; Horwitz, S. M.; Zinzani, P. L.; Van Hoof, A.; Assouline, S. E.; Bhat, G.; Choi, M. R.; Allen, L. F.; Ben-Yehuda, D.; Jurczak, W.; more...
Blood (2014)

Fulltext@MSK | Save

Interim safety analysis: A phase I trial of high dose therapy and autologous stem cell transplantation followed by infusion of chimeric antigen receptor modified T-cells (19-28z CAR-T) directed against CD19+B-cells for relapsed and refractory aggressive B cell non-Hodgkin lymphoma (B-NHL)

Meeting Abstract

Sauter, C. S.; Riviere, I.; Bernal, Y. J.; Wang, X. Y.; Purdon, T. J.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
Blood (2014)

Fulltext@MSK | Save

Double-unit cord blood (CB) transplantation (DCBT) combined with haplo-identical CD34+selected peripheral blood stem cells (PBSC) is associated with enhanced neutrophil recovery, universal haplo rejection and frequent pre-engraftment syndrome

Meeting Abstract

Sanchez, M. E.; Ponce, D. M.; Lauer, E. J.; Lubin, M. N.; Barone, J.; Byam, C.; Dahi, P. B.; Meagher, R.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
Blood (2014)

Fulltext@MSK | Save

Allogeneic transplantation for chronic myelomonocytic leukemia (CMML) is associated with high disease-free survival even in the setting of high-risk disease

Meeting Abstract

Sanchez, M. E.; Abbi, K. K. S.; Tamari, R.; Jakubowski, A.; Papadopoulos, E. B.; Devlin, S. M.; Shi, W. J.; Sauter, C. S.; Barker, J. N.; Boulad, F.; more...
Blood (2014)

Fulltext@MSK | Save